Eaton Vance Worldwide Health Sciences Fund Class C (ECHSX)
| Fund Assets | 860.66M |
| Expense Ratio | 1.92% |
| Min. Investment | $1,000 |
| Turnover | 15.00% |
| Dividend (ttm) | 0.60 |
| Dividend Yield | 4.69% |
| Dividend Growth | 94.57% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 5, 2024 |
| Previous Close | 12.68 |
| YTD Return | -2.16% |
| 1-Year Return | -11.12% |
| 5-Year Return | 21.74% |
| 52-Week Low | 12.15 |
| 52-Week High | 15.70 |
| Beta (5Y) | n/a |
| Holdings | 49 |
| Inception Date | Jan 5, 1998 |
About ECHSX
Eaton Vance Worldwide Health Sciences Fund Class C is a **diversified mutual fund** that targets global opportunities within the health sciences sector. The fund’s primary objective is to **achieve long-term capital growth** by investing in companies engaged in the discovery, development, production, or distribution of products and services connected to scientific advancements in health care. This includes companies in biotechnology, pharmaceuticals, diagnostics, managed health care, and medical equipment and supplies. By allocating assets across a mix of U.S. and international holdings, the fund captures growth trends driven by aging populations, technological innovation, and rising global health expenditures. Its portfolio is concentrated in major health care names, with the top holdings typically representing a substantial percentage of total assets. The fund is managed by a team based in Boston and London, utilizing a stock selection process that emphasizes fundamental value and growth potential, regardless of short-term market volatility. Eaton Vance Worldwide Health Sciences Fund Class C plays a **significant role in providing targeted exposure to the health care industry** within diversified investment portfolios, allowing investors to participate in both domestic and international health innovation and growth trends.
Performance
ECHSX had a total return of -11.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.83%.
Top 10 Holdings
49.07% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.92% |
| AbbVie Inc. | ABBV | 5.66% |
| AstraZeneca PLC | AZN | 5.42% |
| Abbott Laboratories | ABT | 4.99% |
| Roche Holding AG | ROG | 4.79% |
| Novo Nordisk A/S | NOVO.B | 4.66% |
| Zoetis Inc. | ZTS | 3.60% |
| Intuitive Surgical, Inc. | ISRG | 3.53% |
| Johnson & Johnson | JNJ | 3.53% |
| Boston Scientific Corporation | BSX | 2.97% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 5, 2024 | $0.5987 | Dec 6, 2024 |
| Dec 7, 2023 | $0.3077 | Dec 8, 2023 |
| Dec 8, 2022 | $0.5351 | Dec 9, 2022 |
| Dec 9, 2021 | $1.086 | Dec 10, 2021 |
| Dec 10, 2020 | $0.8312 | Dec 11, 2020 |
| Dec 3, 2019 | $0.5422 | Dec 4, 2019 |